Online edition of India's National Newspaper
Thursday, July 12, 2001

Front Page | National | Southern States | Other States | International | Opinion | Business | Sport | Science & Tech | Entertainment | Miscellaneous | Features | Classifieds | Employment | Index | Home

Business | Previous | Next

AA for Glenmark Pharma

A AA (double A) rating has been assigned to the Rs. 45 crore non- convertible debenture issue of Glenmark Pharmaceuticals (Glenmark). Further, the pfAA (pf double A) rating assigned to the Rs. 40 crore preference share programme has been withdrawn to the extent of Rs. 30 crores since the company does not propose to go ahead with the issue.

The rating factors in the company's respectable presence in the anti-fungal, cough and cold, haematinic and cephalosporins antibiotic segments of the domestic market. The acquisition of Lyka brands in 2000-01 further strengthens the company's position in these segments.

Corporate Bureau

Send this article to Friends by E-Mail


Section  : Business
Previous : Ahmedabad Municipal Corporation gets AA
Next     : P1 plus for Hero Honda Finlease

Front Page | National | Southern States | Other States | International | Opinion | Business | Sport | Science & Tech | Entertainment | Miscellaneous | Features | Classifieds | Employment | Index | Home

Copyrights © 2001 The Hindu

Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu